Publicaciones en las que colabora con MIGUEL ANGEL ARÉVALO GÓMEZ (19)

2010

  1. Metformin prevents experimental gentamicin-induced nephropathyby a mitochondria-dependent pathway

    Kidney International, Vol. 77, Núm. 10, pp. 861-869

2006

  1. Endoglin regulates cyclooxygenase-2 expression and activity

    Circulation Research, Vol. 99, Núm. 3, pp. 248-256

  2. Papel de la vía de Ras en un modelo de nefrotoxicidad inducida por cadmio. Efecto protector del antioxidante quercetina

    Revista de Toxicologia, Vol. 23, Núm. 2-3, pp. 130-137

  3. Protective effect of quercetin on experimental chronic cadmium nephrotoxicity in rats is based on its antioxidant properties

    Food and Chemical Toxicology, Vol. 44, Núm. 12, pp. 2092-2100

  4. Reduced angiogenic responses in adult endoglin heterozygous mice

    Cardiovascular Research, Vol. 69, Núm. 4, pp. 845-854

2005

  1. Effect of the long-term treatment with trandolapril on endoglin expression in rats with experimental renal fibrosis induced by renal mass reduction

    Kidney and Blood Pressure Research, Vol. 28, Núm. 1, pp. 32-40

  2. Encapsulation and in vitro evaluation of amikacin-loaded erythrocytes

    Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents, Vol. 12, Núm. 6, pp. 409-416

  3. Temporal changes in renal endoglin and TGF-β1 expression following ureteral obstruction in rats

    Journal of Physiology and Biochemistry, Vol. 61, Núm. 3, pp. 457-467

2004

  1. Erratum: Gentamicin treatment induces simultaneous mesangial proliferation and apoptosis in rats (Kidney International (2004) 65 (2161-2171))

    Kidney International

  2. Gentamicin treatment induces simultaneous mesangial proliferation and apoptosis in rats

    Kidney International, Vol. 65, Núm. 6, pp. 2161-2171

2003

  1. Acute renal toxic effect of amiodarone in rats

    Pharmacology and Toxicology, Vol. 92, Núm. 1, pp. 39-42

2001

  1. Up-regulation of endoglin, a TGF-β-binding protein, in rats with experimental renal fibrosis induced by renal mass reduction

    Nephrology Dialysis Transplantation, Vol. 16, Núm. SUPPL. 1, pp. 34-39

2000

  1. Mechanisms implied in aminoglycoside-induced nephrotoxicity

    Nefrología : publicación oficial de la Sociedad Española Nefrologia, Vol. 20, Núm. 5, pp. 408-414

1998

  1. Pharmacokinetic parameters of netilmicin and protective effect of piperacillin regarding nephrotoxicity caused by netilmicin

    European Journal of Drug Metabolism and Pharmacokinetics

1997

  1. Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat

    Hepatology, Vol. 26, Núm. 3, pp. 527-536

  2. Study on pharmacokinetics and nephrotoxicity of netilmicin in rabbits using a new dosage regimen

    Methods and Findings in Experimental and Clinical Pharmacology, Vol. 19, Núm. 1, pp. 53-59

1996

  1. Reversible impairment of neonatal hepatobiliary function by maternal cholestasis

    Hepatology, Vol. 23, Núm. 5, pp. 1208-1217

1989

  1. Pharmacokinetic and nephrotoxic study of gentamicin in rabbits using a new dosage regimen

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 14, Núm. 2, pp. 169-175

  2. Ultrastructural effects of gentamicin at therapeutic doses on the renal cortex

    Revista Espanola de Quimioterapia, Vol. 2, Núm. 1, pp. 73-77